Effect of prior cancer on outcomes in early stage lung cancer: Implications for clinical trial eligibility and accrual

被引：0
|
作者：
Gerber, David E.
Laccetti, Andrew L.
Pruitt, Sandi
Xuan, Lei
Halm, Ethan
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Texas Southwestern, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6573
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients
    Sepesi, Boris
    Ye, Yuanqing
    Mitchell, Kyle G.
    Zhang, Liren
    Gu, Jianchun
    Ji, Lin
    Antonoff, Mara B.
    Hofstetter, Wayne L.
    Rice, David C.
    Mehran, Reza J.
    Walsh, Garrett L.
    Vaporciyan, Ara A.
    Swisher, Stephen G.
    Roth, Jack A.
    Wu, Xifeng
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2635 - 2643
  • [42] Outcomes of cancer patients who do not satisfy conventional clinical trial eligibility criteria (CTEC)
    Cheung, Winson Y.
    Javaheri, Khodadad Rasool
    Speers, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [43] Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early-Stage Lung Cancer
    Shaikh, Talha
    Churllla, Thomas M.
    Murphy, Colin T.
    Zaorsky, Nicholas G.
    Haber, Alan
    Hallman, Mark A.
    Meyer, Joshua E.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 1112 - 1120
  • [44] With Comparable Outcomes, Should Early-Stage Lung Cancer Be a Contraindication to Lung Transplant?
    Spies, Connor S.
    Ochoa, Timothy N.
    Pontula, Arya
    Harris, Chelsea S.
    Snyder, Laurie D.
    Pavlisko, Elizabeth N.
    Hartwig, Matthew G.
    ANNALS OF THORACIC SURGERY, 2024, 118 (01): : 261 - 267
  • [45] Dietary trial in prostate cancer: Early experience and implications for clinical trial design
    Ornish, DM
    Lee, KL
    Fair, WR
    Pettengill, EB
    Carroll, PR
    UROLOGY, 2001, 57 (4A) : 200 - 201
  • [46] Adjuvant treatment and outcomes in patients with stage III colon cancer (CC) who do not fit clinical trial eligibility criteria (CTEC)
    Javaheri, Khodadad Rasool
    Kennecke, Hagen F.
    Renouf, Daniel John
    Lim, Howard John
    Hsu, Tina
    Speers, Caroline
    Goktepe, Ozge
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [47] Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes
    Chan, Oscar S. H.
    Yeung, Rebecca M. W.
    Hung, Albert W. M.
    Lee, Michael C. H.
    Chang, Amy T. Y.
    Chan, Connie C. C.
    Lee, Anne W. M.
    HONG KONG MEDICAL JOURNAL, 2012, 18 (05) : 412 - 418
  • [48] Diversifying breast cancer clinical trial accrual: An approach to recruitment at a Comprehensive Cancer Center
    Chavez, Tanya A.
    Thai, Christine
    Sanchez, Angelica
    Kruper, Laura L.
    Jones, Veronica C.
    Clancy, Sharon
    Polverini, Amy C.
    Yee, Lisa D.
    Vito, Courtney A.
    Chavez, Noe R.
    Nunez, Alan
    Rippberger, Ellen J.
    Wong, Angela K.
    Herold, Karen
    Kalu, Chidimma M. K.
    Alva-Ornelas, Jackelyn A.
    Tomsic, Jerneja
    Round, Krista M.
    Robles, Margarita
    Idassi, Ombeni
    Kennedy, Kendall J.
    Hyslop, Terry
    Zalles, Carola M.
    Sistrunk, Christopher
    Seewaldt, Victoria L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [49] Stigma in Early Stage Lung Cancer
    Culling, J.
    Bedard, S.
    Turner, S.
    Johnson, S.
    Pellizzari, J.
    Bedard, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S349 - S349
  • [50] Management of Early Stage Lung Cancer
    Ikeda, N.
    Ohira, T.
    Kajiwara, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1619 - S1620
12345